Kidney stones 2012: Pathogenesis, diagnosis, and management

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 6, 2012, Pages 1847-1860

  Sakhaee, Khashayar ^a   Maalouf, Naim M ^a   Sinnott, Bridget ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; ACETOHYDROXAMIC ACID; ALKALI; ALLOPURINOL; AMILORIDE; BENDROFLUMETHIAZIDE; CHLORTALIDONE; CITRATE POTASSIUM; HYDROCHLOROTHIAZIDE; INDAPAMIDE; MAGNESIUM HYDROXIDE; PENICILLAMINE; PLACEBO; PYRIDOXINE; THIAZIDE DIURETIC AGENT; THIOL DERIVATIVE; TIOPRONIN; TRICHLORMETHIAZIDE;

ARTICLE; CALCIUM ABSORPTION; CALCIUM STONE; CAUSAL ATTRIBUTION; CYSTINURIA; DNA POLYMORPHISM; DRUG EFFICACY; DRUG MEGADOSE; ETHNIC DIFFERENCE; FLUID INTAKE; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; HYPERCALCIURIA; HYPEROXALURIA; HYPERURICOSURIA; HYPOCITRATURIA; KIDNEY DISEASE; LABORATORY DIAGNOSIS; NEPHROLITHIASIS; NON CALCIUM NEPHROLITHIASIS; NONHUMAN; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RENAL LEAK HYPERCALCIURIA; SEX DIFFERENCE; STONE ANALYSIS; STONE FORMATION; TREATMENT INDICATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; URIC ACID STONE; URINARY TRACT DISEASE; URINE PH; VITAMIN INTAKE; INCIDENCE; REVIEW; RISK FACTOR;

HUMANS; INCIDENCE; KIDNEY CALCULI; NEPHROLITHIASIS; PREVALENCE; RISK FACTORS;

EID: 84861965021     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-3492     Document Type: Article

References (144)

1. Romero V, Akpinar H, Assimos DG 2010 Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol 12:e86-e96
2. Lieske JC, Peña de la Vega LS, Slezak JM, Bergstralh EJ, Leibson CL, Ho KL, Gettman MT 2006 Renal stone epidemiology in Rochester, Minnesota: an update. Kidney Int 69:760-764
3. Sakhaee K 2008 Nephrolithiasis as a systemic disorder. Curr Opin Nephrol Hypertens 17:304-309 (Pubitemid 351535934)
4. Sakhaee K, Maalouf NM, Kumar R, Pasch A, Moe OW 2011 Nephrolithiasis- associated bone disease: pathogenesis and treatment options. Kidney Int 79:393-403
5. Sakhaee K 2009 Recent advances in the pathophysiology of nephrolithiasis. Kidney Int 75:585-595
6. Uribarri J, Oh MS, Carroll HJ 1989 The first kidney stone. Ann Intern Med 111:1006-1009 (Pubitemid 20034925)
7. Saigal CS, Joyce G, Timilsina AR 2005 Direct and indirect costs of nephrolithiasis in an employed population: opportunity for disease management? Kidney Int 68:1808-1814 (Pubitemid 43169926)
8. Hiatt RA, Dales LG, Friedman GD, Hunkeler EM 1982 Frequency of urolithiasis in a prepaid medical care program. Am J Epidemiol 115:255-265 (Pubitemid 12182304)
9. Mandel NS, Mandel GS 1989 Urinary tract stone disease in the United States veteran population. II. Geographical analysis of variations in composition. J Urol 142:1516-1521 (Pubitemid 20011971)
10. Evan AP, Lingeman JE, Coe FL, Shao Y, Parks JH, Bledsoe SB, Phillips CL, Bonsib S, Worcester EM, Sommer AJ, Kim SC, Tinmouth WW, Grynpas M 2005 Crystal-associated nephropathy in patients with brushite nephrolithiasis. Kidney Int 67:576-591 (Pubitemid 40139849)
11. Pak CY 1991 Etiology and treatment of urolithiasis. Am J Kidney Dis 18:624-637
12. Pak CY, Britton F, Peterson R, Ward D, Northcutt C, Breslau NA, McGuire J, Sakhaee K, Bush S, Nicar M, Norman DA, Peters P 1980 Ambulatory evaluation of nephrolithiasis. Classification, clinical presentation and diagnostic criteria. Am J Med 69:19-30 (Pubitemid 10084682)
13. Flocks RH 1939 Calcium and phosphorus excretion in the urine of patients with renal or ureteral calculi. JAMA 113:1466-1471
14. Albright F, Henneman P, Benedict PH, Forbes AP 1953 Idiopathic hypercalciuria: a preliminary report. Proc R Soc Med 46:1077-1081
15. Henneman PH, Benedict PH, Forbes AP, Dudley HR 1958 Idiopathic hypercaicuria. N Engl J Med 259:802-807
16. Sutton RA, Walker VR 1980 Responses to hydrochlorothiazide and acetazolamide in patients with calcium stones. Evidence suggesting a defect in renal tubular function. N Engl J Med 302:709-713 (Pubitemid 10132097)
17. Sakhaee K, Nicar MJ, Brater DC, Pak CY 1985 Exaggerated natriuretic and calciuric responses to hydrochlorothiazide in renal hypercalciuria but not in absorptive hypercalciuria. J Clin Endocrinol Metab 61:825-829 (Pubitemid 16218475)
18. Worcester EM, Coe FL 2008 New insights into the pathogenesis of idiopathic hypercalciuria. Semin Nephrol 28:120-132 (Pubitemid 351400300)
19. Pak CY, Oata M, Lawrence EC, Snyder W 1974 The hypercalciurias. Causes, parathyroid functions, and diagnostic criteria. J Clin Invest 54:387-400
20. Broadus AE, Insogna KL, Lang R, Mallette LE, Oren DA, Gertner JM, Kliger AS, Ellison AF 1984 A consideration of the hormonal basis and phosphate leak hypothesis of absorptive hypercalciuria. J Clin Endocrinol Metab 58:161-169 (Pubitemid 14220532)
21. Insogna KL, Broadus AE, Dreyer BE, Ellison AF, Gertner JM 1985 Elevated production rate of 1,25-dihydroxyvitamin D in patients with absorptive hypercalciuria. J Clin Endocrinol Metab 61:490-495 (Pubitemid 15243961)
22. Birge SJ, Peck WA, Berman M, Whedon GD 1969 Study of calcium absorption in man: a kinetic analysis and physiologic model. J Clin Invest 48:1705-1713
23. Pak CY, East DA, Sanzenbacher LJ, Delea CS, Bartter FC 1972 Gastrointestinal calcium absorption in nephrolithiasis. J Clin Endocrinol Metab 35:261-270
24. Kaplan RA, Haussler MR, Deftos LJ, Bone H, Pak CY 1977 The role of 1α,25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria. J Clin Invest 59:756-760 (Pubitemid 8096326)
25. Zerwekh JE, Pak CY 1980 Selective effects of thiazide therapy on serum 1α,25-dihydroxyvitamin D and intestinal calcium absorption in renal and absorptive hypercalciurias. Metabolism 29:13-17 (Pubitemid 10208099)
26. Pak CY, Sakhaee K, Moe OW, Poindexter J, Adams-Huet B, Pearle MS, Zerwekh JE, Preminger GM, Wills MR, Breslau NA, Bartter FC, Brater DC, Heller HJ, Odvina CV, Wabner CL, Fordtran JS, Oh M, Garg A, Harvey JA, Alpern RJ, Snyder WH, Peters PC 2011 Defining hypercalciuria in nephrolithiasis. Kidney Int 80:777-782
27. Van Den Berg CJ, Kumar R, Wilson DM, Heath 3rd H, Smith LH 1980 Orthophosphate therapy decreases urinary calcium excretion and serum 1,25-dihydroxyvitamin D concentrations in idiopathic hypercalciuria. J Clin Endocrinol Metab 51:998-1001 (Pubitemid 11225450)
28. Maierhofer WJ, Gray RW, Cheung HS, Lemann Jr J 1983 Bone resorption stimulated by elevated serum 1,25-(OH)2-vitamin D concentrations in healthy men. Kidney Int 24:555-560 (Pubitemid 14209795)
29. Breslau NA, Preminger GM, Adams BV, Otey J, Pak CY 1992 Use of ketoconazole to probe the pathogenetic importance of 1,25-dihydroxyvitamin D in absorptive hypercalciuria. J Clin Endocrinol Metab 75:1446-1452 (Pubitemid 23001400)
30. Barilla DE, Zerwekh J, Pak CY 1979 A critical evaluation of the role of phosphate in the pathogenesis of absorptive hypercalciuria. Miner Electrolyte Metab 2:302-309 (Pubitemid 10222902)
31. Zerwekh JE, Pak CY, Kaplan RA, McGuire JL, Upchurch K, Breslau N, Johnson Jr R 1980 Pathogenetic role of 1α,25-dihydroxyvitamin D in sarcoidosis and absorptive hypercalciuria: different response to prednisolone therapy. J Clin Endocrinol Metab 51:381-386 (Pubitemid 10007653)
32. Bushinsky DA, Grynpas MD, Nilsson EL, Nakagawa Y, Coe FL 1995 Stone formation in genetic hypercalciuric rats. Kidney Int 48:1705-1713
33. Bushinsky DA, Asplin JR, Grynpas MD, Evan AP, Parker WR, Alexander KM, Coe FL 2002 Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats. Kidney Int 61:975-987 (Pubitemid 34175466)
34. Li XQ, Tembe V, Horwitz GM, Bushinsky DA, Favus MJ 1993 Increased intestinal vitamin D receptor in genetic hypercalciuric rats. A cause of intestinal calcium hyperabsorption. J Clin Invest 91:661-667 (Pubitemid 23064152)
35. Tsuruoka S, Bushinsky DA, Schwartz GJ 1997 Defective renal calcium reabsorption in genetic hypercalciuric rats. Kidney Int 51:1540-1547 (Pubitemid 27239910)
36. Karnauskas AJ, van Leeuwen JP, van den Bemd GJ, Kathpalia PP, DeLuca HF, Bushinsky DA, Favus MJ 2005 Mechanism and function of high vitamin D receptor levels in genetic hypercalciuric stone-forming rats. J Bone Miner Res 20:447-454 (Pubitemid 40293493)
37. Zerwekh JE, Yu XP, Breslau NA, Manolagas S, Pak CY 1993 Vitamin D receptor quantitation in human blood mononuclear cells in health and disease. Mol Cell Endocrinol 96:1-6 (Pubitemid 23292655)
38. Favus MJ, Karnauskas AJ, Parks JH, Coe FL 2004 Peripheral blood monocyte vitamin D receptor levels are elevated in patients with idiopathic hypercalciuria. J Clin Endocrinol Metab 89:4937-4943 (Pubitemid 39391431)
39. Coe FL, Bushinsky DA 1984 Pathophysiology of hypercalciuria. Am J Physiol 247:F1-F13 (Pubitemid 14091523)
40. Pak CY, Nicar MJ, Peterson R, Zerwekh JE, Snyder W 1981 Alack of unique pathophysiologic background for nephrolithiasis of primary hyperparathyroidism. J Clin Endocrinol Metab 53:536-542 (Pubitemid 12005795)
41. Rejnmark L, Vestergaard P, Mosekilde L 2011 Nephrolithiasis and renal calcifications in primary hyperparathyroidism. J Clin Endocrinol Metab 96:2377-2385
42. Patron P, Gardin JP, Paillard M 1987 Renal mass and reserve of vitamin D: determinants in primary hyperparathyroidism. Kidney Int 31:1174-1180 (Pubitemid 17069102)
43. Odvina CV, Sakhaee K, Heller HJ, Peterson RD, Poindexter JR, Padalino PK, Pak CY 2007 Biochemical characterization of primary hyperparathyroidism with and without kidney stones. Urol Res 35:123-128 (Pubitemid 46828954)
44. Preminger GM 1992 Renal calculi: pathogenesis, diagnosis, and medical therapy. Semin Nephrol 12:200-216
45. Coe FL 1978 Hyperuricosuric calcium oxalate nephrolithiasis. Kidney Int 13:418-426 (Pubitemid 8349995)
46. Coe FL, Parks JH 1981 Hyperuricosuria and calcium nephrolithiasis. Urol Clin North Am 8:227-244 (Pubitemid 11040104)
47. Pak CY, Arnold LH 1975 Heterogeneous nucleation of calcium oxalate by seeds of monosodium urate. Proc Soc Exp Biol Med 149:930-932
48. Grover PK, Ryall RL 1994 Urate and calcium oxalate stones: from repute to rhetoric to reality. Miner Electrolyte Metab 20:361-370
49. Curhan GC, Taylor EN 2008 24-h uric acid excretion and the risk of kidney stones. Kidney Int 73:489-496 (Pubitemid 351186291)
50. Pak CY 1994 Citrate and renal calculi: an update. Miner Electrolyte Metab 20:371-377
51. Hamm LL 1990 Renal handling of citrate. Kidney Int 38:728-735 (Pubitemid 20299427)
52. Aruga S, Wehrli S, Kaissling B, Moe OW, Preisig PA, Pajor AM, Alpern RJ 2000 Chronic metabolic acidosis increases NaDC-1 mRNA and protein abundance in rat kidney. Kidney Int 58:206-215 (Pubitemid 30429865)
53. Backman U, Danielson BG, Johansson G, Ljunghall S, Wikström B 1980 Incidence and clinical importance of renal tubular defects in recurrent renal stone formers. Nephron 25:96-101 (Pubitemid 10168503)
54. Gordon EE, Sheps SG 1957 Effect of acetazolamide on citrate excretion and formation of renal calculi. N Engl J Med 256:1215-1219
55. Welch BJ, Graybeal D, Moe OW, Maalouf NM, Sakhaee K 2006 Biochemical and stone-risk profiles with topiramate treatment. Am J Kidney Dis 48:555-563 (Pubitemid 44402839)
56. Alpern RJ, Sakhaee K 1997 The clinical spectrum of chronic metabolic acidosis: homeostatic mechanisms produce significant morbidity. Am J Kidney Dis 29:291-302 (Pubitemid 27130744)
57. Preminger GM, Sakhaee K, Skurla C, Pak CY 1985 Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis. J Urol 134:20-23 (Pubitemid 15006779)
58. Pak CY, Peterson R, Sakhaee K, Fuller C, Preminger G, Reisch J 1985 Correction of hypocitraturia and prevention of stone formation by combined thiazide and potassium citrate therapy in thiazide-unresponsive hypercalciuric nephrolithiasis. Am J Med 79:284-288 (Pubitemid 15232500)
59. Shey J, Cameron MA, Sakhaee K, Moe OW 2004 Recurrent calcium nephrolithiasis associated with primary aldosteronism. Am J Kidney Dis 44:e7-e12 (Pubitemid 38880942)
60. Reddy ST, Wang CY, Sakhaee K, Brinkley L, Pak CY 2002 Effect of low-carbohydrate high-protein diets on acid-base balance, stone-forming propensity, and calcium metabolism. Am J Kidney Dis 40:265-274 (Pubitemid 34827643)
61. Sakhaee K, Harvey JA, Padalino PK, Whitson P, Pak CY 1993 The potential role of salt abuse on the risk for kidney stone formation. J Urol 150:310-312 (Pubitemid 23215857)
62. Melnick JZ, Preisig PA, Haynes S, Pak CY, Sakhaee K, Alpern RJ 1998 Converting enzyme inhibition causes hypocitraturia independent of acidosis or hypokalemia. Kidney Int 54:1670-1674 (Pubitemid 28502909)
63. Kok DJ, Papapoulos SE, Bijvoet OL 1986 Excessive crystal agglomeration with low citrate excretion in recurrent stone-formers. Lancet 1:1056-1058 (Pubitemid 16106265)
64. Holmes RP, Goodman HO, Assimos DG 2001 Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int 59:270-276 (Pubitemid 32055235)
65. Danpure CJ, Jennings PR 1986 Peroxisomal alanine:glyoxylate aminotransferase deficiency in primary hyperoxaluria type I. FEBS Lett 201:20-24 (Pubitemid 16072347)
66. Giafi CF, Rumsby G 1998 Kinetic analysis and tissue distribution of human D-glycerate dehydrogenase/glyoxylate reductase and its relevance to the diagnosis of primary hyperoxaluria type 2. Ann Clin Biochem 35:104-109 (Pubitemid 28043633)
67. Belostotsky R, Seboun E, Idelson GH, Milliner DS, Becker-Cohen R, Rinat C, Monico CG, Feinstein S, Ben-Shalom E, Magen D, Weissman I, Charon C, Frishberg Y 2010 Mutations in DHDPSL are responsible for primary hyperoxaluria type III. Am J Hum Genet 87:392-399
68. Monico CG, Rossetti S, Belostotsky R, Cogal AG, Herges RM, Seide BM, Olson JB, Bergstrahl EJ, Williams HJ, Haley WE, Frishberg Y, Milliner DS 2011 Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasis. Clin J Am Soc Nephrol 6:2289-2295
69. Hoppe B, Beck B, Gatter N, von Unruh G, Tischer A, Hesse A, Laube N, Kaul P, Sidhu H 2006 Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1. Kidney Int 70:1305-1311 (Pubitemid 44435182)
70. Monico CG, Weinstein A, Jiang Z, Rohlinger AL, Cogal AG, Bjornson BB, Olson JB, Bergstralh EJ, Milliner DS, Aronson PS 2008 Phenotypic and functional analysis of human SLC26A6 variants in patients with familial hyperoxaluria and calcium oxalate nephrolithiasis. Am J Kidney Dis 52:1096-1103
71. Jiang Z, Asplin JR, Evan AP, Rajendran VM, Velazquez H, Nottoli TP, Binder HJ, Aronson PS 2006 Calcium oxalate urolithiasis in mice lacking anion transporter Slc26a6. Nat Genet 38:474-478
72. Maalouf NM, Tondapu P, Guth ES, Livingston EH, Sakhaee K 2010 Hypocitraturia and hyperoxaluria after Roux-en-Y gastric bypass surgery. J Urol 183:1026-1030
73. Lindsjö M, Danielson BG, Fellström B, Ljunghall S 1989 Intestinal oxalate and calcium absorption in recurrent renal stone formers and healthy subjects. Scand J Urol Nephrol 23:55-59 (Pubitemid 19054556)
74. Dobbins JW, Binder HJ 1976 Effect of bile salts and fatty acids on the colonic absorption of oxalate. Gastroenterology 70:1096-1100
75. Pak CY, Poindexter JR, Adams-Huet B, Pearle MS 2003 Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am J Med 115:26-32 (Pubitemid 36831118)
76. Parks JH, Worcester EM, Coe FL, Evan AP, Lingeman JE 2004 Clinical implications of abundant calcium phosphate in routinely analyzed kidney stones. Kidney Int 66:777-785 (Pubitemid 38982022)
77. Coe FL, Evan A, Worcester E 2011 Pathophysiology-based treatment of idiopathic calcium kidney stones. Clin J Am Soc Nephrol 6:2083-2092
78. Ljunghall S, Danielson BG, Fellström B, Holmgren K, Johansson G, Wikström B 1985 Family history of renal stones in recurrent stone patients. Br J Urol 57:370-374 (Pubitemid 15226368)
79. Goldfarb DS, Fischer ME, Keich Y, Goldberg J 2005 A twin study of genetic and dietary influences on nephrolithiasis: a report from the Vietnam Era Twin (VET) Registry. Kidney Int 67:1053-1061 (Pubitemid 41623330)
80. Reed BY, Heller HJ, Gitomer WL, Pak CY 1999 Mapping a gene defect in absorptive hypercalciuria to chromosome 1q23.3-q24. J Clin Endocrinol Metab 84:3907-3913 (Pubitemid 30644173)
81. Thorleifsson G, Holm H, Edvardsson V, Walters GB, Styrkarsdottir U, Gudbjartsson DF, Sulem P, Halldorsson BV, de Vegt F, d'Ancona FC, den Heijer M, Franzson L, Christiansen C, Alexandersen P, Rafnar T, Kristjansson K, Sigurdsson G, Kiemeney LA, Bodvarsson M, Indridason OS, Palsson R, Kong A, Thorsteinsdottir U, Stefansson K 2009 Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. Nat Genet 41:926-930
82. Shakhssalim N, Kazemi B, Basiri A, Houshmand M, Pakmanesh H, Golestan B, Eilanjegh AF, Kashi AH, Kilani M, Azadvari M 2010 Association between calcium-sensing receptor gene polymorphisms and recurrent calcium kidney stone disease: a comprehensive gene analysis. Scand J Urol Nephrol 44:406-412
83. Maalouf NM, Cameron MA, Moe OW, Sakhaee K 2004 Novel insights into the pathogenesis of uric acid nephrolithiasis. Curr Opin Nephrol Hypertens 13:181-189 (Pubitemid 38373140)
84. Sakhaee K, Adams-Huet B, Moe OW, Pak CY 2002 Pathophysiologic basis for normouricosuric uric acid nephrolithiasis. Kidney Int 62:971-979 (Pubitemid 35316727)
85. Sakhaee K 2010 Uric acid metabolism and uric acid stones. In: Rao NP, Preminger G, Kavanaugh J, eds. Urinary tract stone disease. London: BC Decker Publisher, Springer-Verlag
86. Bobulescu IA, Dubree M, Zhang J, McLeroy P, Moe OW 2008 Effect of renal lipid accumulation on proximal tubule Na+/H+exchange and ammonium secretion. Am J Physiol Renal Physiol 294:F1315-F1322
87. Bobulescu IA, Dubree M, Zhang J, McLeroy P, Moe OW 2009 Reduction of renal triglyceride accumulation: effects on proximal tubule Na+/H+ exchange and urinary acidification. Am J Physiol Renal Physiol 297:F1419-F1426
88. Ichida K, Hosoyamada M, Hisatome I, Enomoto A, Hikita M, Endou H, Hosoya T 2004 Clinical and molecular analysis of patients with renal hypouricemia in Japan - influence of URAT1 gene on urinary urate excretion. J Am Soc Nephrol 15:164-173 (Pubitemid 38020708)
89. Ombra MN, Forabosco P, Casula S, Angius A, Maestrale G, Petretto E, Casu G, Colussi G, Usai E, Melis P, Pirastu M 2001 Identification of anewcandidate locus for uric acid nephrolithiasis. Am J Hum Genet 68:1119-1129 (Pubitemid 32424411)
90. Gianfrancesco F, Esposito T, Ombra MN, Forabosco P, Maninchedda G, Fattorini M, Casula S, Vaccargiu S, Casu G, Cardia F, Deiana I, Melis P, Falchi M, Pirastu M 2003 Identification of a novel gene and a common variant associated with uric acid nephrolithiasis in a Sardinian genetic isolate. Am J Hum Genet 72: 1479-1491 (Pubitemid 36628387)
91. Chillarón J, Font-Llitjós M, Fort J, Zorzano A, Goldfarb DS, Nunes V, Palacín M 2010 Pathophysiology and treatment of cystinuria. Nat Rev Nephrol 6:424-434
92. Sakhaee K 1996 Pathogenesis and medical management of cystinuria. Semin Nephrol 16:435-447 (Pubitemid 26320152)
93. Dello Strologo L, Pras E, Pontesilli C, Beccia E, Ricci-Barbini V, de Sanctis L, Ponzone A, Gallucci M, Bisceglia L, Zelante L, Jimenez-Vidal M, Font M, Zorzano A, Rousaud F, Nunes V, Gasparini P, Palacín M, Rizzoni G 2002 Comparison between SLC3A1 and SLC7A9 cystinuria patients and carriers: a need for a new classification. J Am Soc Nephrol 13:2547-2553
94. Font-Llitjós M, Jiménez-Vidal M, Bisceglia L, Di Perna M, de Sanctis L, Rousaud F, Zelante L, Palacín M, Nunes V 2005 New insights into cystinuria: 40 new mutations, genotype-phenotype correlation, and digenic inheritance causing partial phenotype. J Med Genet 42:58-68
95. Bichler KH, Eipper E, Naber K, Braun V, Zimmermann R, Lahme S 2002 Urinary infection stones. Int J Antimicrob Agents 19:488-498 (Pubitemid 34831653)
96. Maalouf NM, Moe OW, Adams-Huet B, Sakhaee K 2011 Hypercalciuria associated with high dietary protein intake is not due to acid load. J Clin Endocrinol Metab 96:3733-3740
97. Curhan GC, Willett WC, Rimm EB, Stampfer MJ 1993 A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 328:833-838 (Pubitemid 23084337)
98. Curhan GC, Willett WC, Speizer FE, Spiegelman D, Stampfer MJ 1997 Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med 126:497-504 (Pubitemid 27143627)
99. Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, Bassford T, Beresford SA, Black HR, Blanchette P, Bonds DE, Brunner RL, Brzyski RG, Caan B, Cauley JA, Chlebowski RT, Cummings SR, Granek I, Hays J, Heiss G, Hendrix SL, Howard BV, Hsia J, Hubbell FA, Johnson KC, Judd H, Kotchen JM, Kuller LH, Langer RD, Lasser NL, Limacher MC, Ludlam S, Manson JE, Margolis KL, McGowan J, Ockene JK, O'Sullivan MJ, Phillips L, Prentice RL, Sarto GE, Stefanick ML, Van Horn L, Wactawski- Wende J, Whitlock E, Anderson GL, Assaf AR, Barad D 2006 Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 354:669-683 (Pubitemid 43247138)
100. Knohl SJ, Scheinman SJ 2004 Inherited hypercalciuric syndromes: Dent's disease (CLC-5) and familial hypomagnesemia with hypercalciuria (paracellin-1). Semin Nephrol 24:55-60 (Pubitemid 38141845)
101. Bockenhauer D, Bokenkamp A, van't Hoff W, Levtchenko E, Kistvan Holthe JE, Tasic V, Ludwig M 2008 Renal phenotype in Lowe syndrome: a selective proximal tubular dysfunction. Clin J Am Soc Nephrol 3:1430-1436
102. Karet FE 2002 Inherited distal renal tubular acidosis. J Am Soc Nephrol 13:2178-2184 (Pubitemid 34790797)
103. Shokeir AA, Abdulmaaboud M 2001 Prospective comparison of nonenhanced helical computerized tomography and Doppler ultrasonography for the diagnosis of renal colic. J Urol 165:1082-1084 (Pubitemid 32210205)
104. Pak CY, Peterson R, Poindexter JR 2001 Adequacy of a single stone risk analysis in the medical evaluation of urolithiasis. J Urol 165:378-381 (Pubitemid 32060417)
105. Parks JH, Goldfisher E, Asplin JR, Coe FL 2002 A single 24-hour urine collection is inadequate for the medical evaluation of nephrolithiasis. J Urol 167:1607-1612 (Pubitemid 34240683)
106. Parks JH, Coe FL 1996 The financial effects of kidney stone prevention. Kidney Int 50:1706-1712 (Pubitemid 26364279)
107. Werness PG, Brown CM, Smith LH, Finlayson B 1985 EQUIL2: a BASIC computer program for the calculation of urinary saturation. J Urol 134:1242-1244 (Pubitemid 16207045)
108. Moe OW, Pearle MS, Sakhaee K 2011 Pharmacotherapy of urolithiasis: evidence from clinical trials. Kidney Int 79:385-392
109. Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A 1996 Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol 155:839-843 (Pubitemid 26052660)
110. Curhan GC, Willett WC, Speizer FE, Stampfer MJ 1998 Beverage use and risk for kidney stones in women. Ann Intern Med 128:534-540 (Pubitemid 28177660)
111. Taylor EN, Curhan GC 2008 Fructose consumption and the risk of kidney stones. Kidney Int 73:207-212
112. Goodman JW, Asplin JR, Goldfarb DS 2009 Effect of two sports drinks on urinary lithogenicity. Urol Res 37:41-46
113. Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, Novarini A 2002 Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 346:77-84 (Pubitemid 34438897)
114. Hiatt RA, Ettinger B, Caan B, Quesenberry Jr CP, Duncan D, Citron JT 1996 Randomized controlled trial of a low animal protein, high fiber diet in the prevention of recurrent calcium oxalate kidney stones. Am J Epidemiol 144:25-33 (Pubitemid 26225284)
115. Traxer O, Huet B, Poindexter J, Pak CY, Pearle MS 2003 Effect of ascorbic acid consumption on urinary stone risk factors. J Urol 170:397-401 (Pubitemid 36870209)
116. Meschi T, Maggiore U, Fiaccadori E, Schianchi T, Bosi S, Adorni G, Ridolo E, Guerra A, Allegri F, Novarini A, Borghi L 2004 The effect of fruits and vegetables on urinary stone risk factors. Kidney Int 66:2402-2410
117. Laerum E, Larsen S 1984 Thiazide prophylaxis of urolithiasis. A double-blind study in general practice. Acta Med Scand 215:383-389 (Pubitemid 14111516)
118. Ettinger B, Citron JT, Livermore B, Dolman LI 1988 Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. J Urol 139:679-684
119. Ohkawa M, Tokunaga S, Nakashima T, Orito M, Hisazumi H 1992 Thiazide treatment for calcium urolithiasis in patients with idiopathic hypercalciuria. Br J Urol 69:571-576
120. Borghi L, Meschi T, Guerra A, Novarini A 1993 Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences. J Cardiovasc Pharmacol 22(Suppl 6):S78-S86 (Pubitemid 23346741)
121. Yendt ER, Guay GF, Garcia DA 1970 The use of thiazides in the prevention of renal calculi. Can Med Assoc J 102:614-620
122. Coe FL, Kavalach AG 1974 Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis. N Engl J Med 291:1344-1350
123. Coe FL 1977 Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria, hyperuricosuria, or no metabolic disorder. Ann Intern Med 87:404-410 (Pubitemid 8217077)
124. Yendt ER, Cohanim M 1978 Prevention of calcium stones with thiazides. Kidney Int 13:397-409 (Pubitemid 8349993)
125. Backman U, Danielson BG, Johansson G, Ljunghall S, Wikström B 1979 Effects of therapy with bendroflumethiazide in patients with recurrent renal calcium stones. Br J Urol 51:175-180 (Pubitemid 9191609)
126. Maschio G, Tessitore N, D'Angelo A, Fabris A, Pagano F, Tasca A, Graziani G, Aroldi A, Surian M, Colussi G, Mandressi A, Trinchieri A, Rocco F, Ponticelli C, Minetti L 1981 Prevention of calcium nephrolithiasis with low-dose thiazide, amiloride and allopurinol. Am J Med 71:623-626 (Pubitemid 12140430)
127. Pak CY, Peters P, Hurt G, Kadesky M, Fine M, Reisman D, Splann F, Caramela C, Freeman A, Britton F, Sakhaee K, Breslau NA 1981 Is selective therapy of recurrent nephrolithiasis possible? Am J Med 71:615-622 (Pubitemid 12140429)
128. Nicar MJ, Peterson R, Pak CY 1984 Use of potassium citrate as potassium supplement during thiazide therapy of calcium nephrolithiasis. J Urol 131:430-433 (Pubitemid 14194688)
129. Pak CY, Fuller C, Sakhaee K, Preminger GM, Britton F 1985 Long-term treatment of calcium nephrolithiasis with potassium citrate. J Urol 134:11-19 (Pubitemid 15006778)
130. Pak CY, Sakhaee K, Fuller C 1986 Successful management of uric acid nephrolithiasis with potassium citrate. Kidney Int 30:422-428 (Pubitemid 16029514)
131. Barcelo P, Wuhl O, Servitge E, Rousaud A, Pak CY 1993 Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol 150:1761-1764 (Pubitemid 24350792)
132. Hofbauer J, Hö barth K, Szabo N, Marberger M 1994 Alkali citrate prophylaxis in idiopathic recurrent calcium oxalate urolithiasis - a prospective randomized study. Br J Urol 73:362-365
133. Ettinger B, Pak CY, Citron JT, Thomas C, Adams-Huet B, Vangessel A 1997 Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol 158:2069-2073 (Pubitemid 27481329)
134. Soygü r T, Akbay A, Kü peli S 2002 Effect of potassium citrate therapy on stone recurrence and residual fragments after shockwave lithotripsy in lower caliceal calcium oxalate urolithiasis: a randomized controlled trial. J Endourol 16:149-152
135. Kang DE, Maloney MM, Haleblian GE, Springhart WP, Honeycutt EF, Eisenstein EL 2007 Effect of medical management on recurrent stone formation following percutaneous nephrolithotomy. J Urol 177:1785-1788; discussion 1788-1789
136. Sakhaee K, Nicar M, Hill K, Pak CY 1983 Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts. Kidney Int 24:348-352 (Pubitemid 13023903)
137. Ettinger B, Tang A, Citron JT, Livermore B, Williams T 1986 Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med 315:1386-1389 (Pubitemid 17055411)
138. Barbey F, Joly D, Rieu P, Méjean A, Daudon M, Jungers P 2000 Medical treatment of cystinuria: critical reappraisal of long-term results. J Urol 163:1419-1423 (Pubitemid 30226286)
139. Dahlberg PJ, van den Berg, Kurtz SB, Wilson DM, Smith LH 1977 Clinical features and management of cystinuria. Mayo Clin Proc 52:533-542
140. Pak CY, Fuller C, Sakhaee K, Zerwekh JE, Adams BV 1986 Management of cystine nephrolithiasis with α-mercaptopropionylglycine. J Urol 136:1003-1008
141. Chow GK, Streem SB 1996 Medical treatment of cystinuria: results of contemporary clinical practice. J Urol 156:1576-1578 (Pubitemid 26343995)
142. Williams JJ, Rodman JS, Peterson CM 1984 A randomized double-blind study of acetohydroxamic acid in struvite nephrolithiasis. N Engl J Med 311:760-764 (Pubitemid 14026226)
143. Griffith DP, Khonsari F, Skurnick JH, James KE 1988 A randomized trial of acetohydroxamic acid for the treatment and prevention of infection-induced urinary stones in spinal cord injury patients. J Urol 140:318-324
144. Griffith DP, Gleeson MJ, Lee H, Longuet R, Deman E, Earle N 1991 Randomized, double-blind trial of Lithostat (acetohydroxamic acid) in the palliative treatment of infection-induced urinary calculi. Eur Urol 20:243-247